Ashford Capital Management Inc Eli Lilly & CO Transaction History

Ashford Capital Management Inc

$678 Million
Q1 2024

A detailed history of Ashford Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Ashford Capital Management Inc holds 508 shares of LLY stock, worth $456,234. This represents 0.06% of its overall portfolio holdings.

Number of Shares

508

Previous 576 11.81%

Holding current value

$456,234

Previous $335,000 17.91%

% of portfolio

0.06%

Previous 0.05%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $40,269 - $53,875	-68 Reduced 11.81%	508 $395,000
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $26,259 - $30,956	-50 Reduced 7.99%	576 $335,000
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $24,902 - $33,297	-71 Reduced 10.19%	626 $293,000
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $11,803 - $13,863	-38 Reduced 5.17%	697 $239,000
Q3 2022 Nov 15, 2022	SELL	$296.48 - $337.87 $32,019 - $36,489	-108 Reduced 12.81%	735 $238,000

Q4 2021 Feb 15, 2022	BUY	$224.85 - $279.04 $189,548 - $235,230	843 New	843 $233,000
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $199,736 - $231,031	-1,366 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$136.42 - $164.18 $186,349 - $224,269	1,366 New	1,366 $224,000
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $197,861 - $244,895	-1,662 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $15,396 - $19,069	-144 Reduced 7.97%	1,662 $218,000
Q3 2019 Nov 15, 2019	SELL	$106.79 - $116.16 $74,646 - $81,195	-699 Reduced 27.9%	1,806 $202,000
Q2 2018 Aug 15, 2018	BUY	$75.7 - $86.88 $189,628 - $217,634	2,505 New	2,505 $214,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $185,896 - $219,438	-2,505 Closed	0 $0
Q2 2017 Aug 21, 2017	BUY	N/A	2,505	2,505 $206,000

Others Institutions Holding LLY

# of Institutions

3,722

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $853B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashford Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ashford Capital Management Inc with notifications on news.

Account

Ashford Capital Management Inc Eli Lilly & CO Transaction History